ADVERTISEMENT

Dan Michel, PharmD

Long-Term Safety and Tolerability of Once-Daily Valbenazine in Patients With Tardive Dyskinesia

Objective: To evaluate the long-term safety and tolerability of once-daily valbenazine in adults with tardive dyskinesia (TD).

Dan Michel , PharmD;

Joshua Burke , MS;

Scott Siegert , PharmD;

Khodayar Farahmand , PharmD;

Martha Sajatovic , MD;

Stephen Marder , MD;

03/01/2019

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Advertisement

Advertisement

Advertisement

Upcoming Events

November 6 ⁠–⁠ November 8

NEI Congress

November 7 ⁠–⁠ November 10

WoundCon

November 8

November 8 ⁠–⁠ November 10

Dermatology Week

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

See Full Calendar

Advertisement

Advertisement